Collegium Pharmaceutical reported quarterly EPS of $1.92, beating the Zacks Consensus Estimate of $1.68 by $0.24 (about 14%). EPS was also up from $1.68 a year ago. The earnings beat is likely a modest positive catalyst for the stock.
Collegium Pharmaceutical reported quarterly EPS of $1.92, beating the Zacks Consensus Estimate of $1.68 by $0.24 (about 14%). EPS was also up from $1.68 a year ago. The earnings beat is likely a modest positive catalyst for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
